http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014200037-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74487f7403edef60f9293ecb4f72065d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2014-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2db25f2c1b7764ae8be45d87adbe81e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c5669910d2be44e3faebf16b9eb51dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_186ded1bdba8911933c5e2bf706acc3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a08baa43d38b1c3ece5bd6a559d58f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c042170f5b1753e6ea7fde8475a73a |
publicationDate | 2014-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2014200037-A1 |
titleOfInvention | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
abstract | The disclosure describes alterations in ERG gene expression. ERG isoforms and promoter sequence of the ERG gene that are involved in, or associated with, prostate cancer are provided. The disclosure further provides therapeutic compositions and methods of detecting, diagnosing, prognosing, and treating prostate cancer, including biomarkers for detecting the expression of two or more of the following genes PSA/KLK3, PMEPAI, NKX3. 1, ODC1, AMDI, and ERG. 4997610_1 (GHMatters) P80589.AU.1 |
priorityDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1286.